Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients.
about
Can lipoprotein-associated phospholipase A2 be used as a predictor of long-term outcome in patients with acute coronary syndrome?Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literatureAdmission lipoprotein-associated phospholipase A2 activity is not associated with long-term clinical outcomes after ST-segment elevation myocardial infarction.Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.Lp-PLA2 Inhibition-The Atherosclerosis Panacea?Lipoprotein-associated phospholipase-A2 activity and its diagnostic potential in patients with acute coronary syndrome and acute ischemic stroke.Lp-PLA2 Inhibitors for the Reduction of Cardiovascular EventsModulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2Alteration in lipoprotein-associated phospholipase A2 levels during acute coronary syndrome and its relationship to standard biomarkers.Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study.Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target.The incremental value of lipids and inflammatory biomarkers in determining residual cardiovascular risk.Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease.Omega-3 fatty acids and lipoprotein associated phospholipase A(2) in healthy older adult males and females.Effect of Selective Thrombus Aspiration on Serum Lipoprotein-Associated Phospholipase A2 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention with High Thrombus Burden.Lipoprotein-Associated Phospholipase A2 is Linked with Poor Cardio-Metabolic Profile in Patients with Ischemic Stroke: A Study of Effects of StatinsLp-PLA2 et sPLA2
P2860
Q26853640-77A65101-216E-48ED-9126-5BA2511AE54DQ33536648-66E2870F-C01A-49FB-82A3-52F4AC7695CAQ33553503-9A04FC69-1DFD-4350-B4AE-6FB4B5B3971FQ33602983-7B81CCA4-8ECD-494C-86BF-504BF39BC581Q33664272-F68BCB7D-8A22-48F0-A462-4DA58DE88C39Q33764961-F8AD1AC8-4E07-483F-A54C-A4329314AF9EQ33936097-B6CC01EA-7355-4F03-91D0-8E50E7652F62Q36145180-1D70A947-0AAB-4608-A2A1-999E89B42D01Q36552187-3E82735F-4AF5-4F3B-A4C0-CE9354645DCDQ36808689-1D213EC5-E42E-42B3-A417-7182C635E6DAQ36913018-BCFAF2F2-BF3C-4BD0-803F-A4B7272DD44CQ37445865-A6ACC01E-CFFC-424F-AAEB-C0EE3EF39438Q37902963-5B74E192-71F9-495F-9EA4-F1A15F8879A6Q39050736-02F6A824-DCDE-4046-9785-9267E40A6BF3Q51393272-AA901760-C52A-4509-8258-6EC3EB25CEBEQ55279006-3160CCC4-983E-4E1A-9534-58427ECE6E71Q57057962-3F8A1B9E-961A-4666-887D-574885E507F3Q58148425-571D5D82-41E6-4FD9-8303-BAD75AE3EB61
P2860
Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Lipoprotein-associated phospho ...... te coronary syndrome patients.
@en
type
label
Lipoprotein-associated phospho ...... te coronary syndrome patients.
@en
prefLabel
Lipoprotein-associated phospho ...... te coronary syndrome patients.
@en
P356
P1476
Lipoprotein-associated phospho ...... te coronary syndrome patients.
@en
P2093
Jonas Oldgren
Stefan K James
P304
P356
10.1093/EURHEARTJ/EHL565
P577
2007-02-21T00:00:00Z